Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Caribou Biosciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 1.28 · gapped above the open, then crossed back over prior close. High/low 1.32 at 7:45 am ET, 1.26 at 11:30 am ET.
CRBU (Caribou Biosciences, Inc.) has 9 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: NTLA +0.09%, in healthcare.
136 institutional managers report a position in Caribou Biosciences, Inc. worth $85.3M between them, filed on form 13F for the quarter ending 2026-06-30. 19 of them hold 80% of it, the largest being BlackRock, Inc. at 16.13%.
111 more managers in the register
19 managers hold 80% of the $85.3M institutional base. The other 117 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Pfizer Inc, GSA Capital Partners LLP, Marshall Wace LLP +1 more · 9.24% of CRBU, 12.28% of CRDF
via Pfizer Inc, Jacobs Levy Equity Management, Inc, Marshall Wace LLP +1 more · 9.24% of CRBU, 18.96% of PYXS
via Kynam Capital Management, LP, Acadian Asset Management LLC, Mackenzie Financial Corp +2 more · 5.16% of CRBU, 4.13% of ALEC
via Pfizer Inc, Acadian Asset Management LLC, Qube Research & Technologies Ltd +4 more · 9.24% of CRBU, 5.98% of ARVN
via Pfizer Inc, GSA Capital Partners LLP, Bridgeway Capital Management Inc · 9.24% of CRBU, 11.14% of SPRO
via Mackenzie Financial Corp, Acadian Asset Management LLC, GSA Capital Partners LLP +1 more · 7.53% of CRBU, 8.78% of FBIO
Managers holding a meaningful stake in CRBU also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.